Skip to main content
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 2018 May 7;115(20):E4731. doi: 10.1073/pnas.1806694115

Correction for Martin-Sanchez et al., TWEAK and RIPK1 mediate a second wave of cell death during AKI

PMCID: PMC5960344  PMID: 29735703

CELL BIOLOGY Correction for “TWEAK and RIPK1 mediate a second wave of cell death during AKI,” by Diego Martin-Sanchez, Miguel Fontecha-Barriuso, Susana Carrasco, Maria Dolores Sanchez-Niño, Anne von Mässenhausen, Andreas Linkermann, Pablo Cannata-Ortiz, Marta Ruiz-Ortega, Jesus Egido, Alberto Ortiz, and Ana Belen Sanz, which was first published March 27, 2018; 10.1073/pnas.1716578115 (Proc Natl Acad Sci USA 115:4182–4187).

The authors note that the affiliations for Jesus Egido appeared incorrectly. The correct affiliations should appear as Instituto Reina Sofía de Investigación Nefrológica, School of Medicine, UAM, 28040 Madrid, Spain; and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Research Institute-Fundación Jiménez Díaz, UAM, 28040 Madrid, Spain. The corrected author and affiliation lines appear below. The online version has been corrected.

Diego Martin-Sancheza, Miguel Fontecha-Barriusoa, Susana Carrascoa, Maria Dolores Sanchez-Niñoa, Anne von Mässenhausenb, Andreas Linkermannb, Pablo Cannata-Ortizc, Marta Ruiz-Ortegaa,d, Jesus Egidoe,f, Alberto Ortiza,e, and Ana Belen Sanza

aRed de Investigacion Renal (REDINREN), Research Institute–Fundación Jiménez Díaz, Autonomous University of Madrid (UAM), 28040 Madrid, Spain; bDepartment of Internal Medicine III, Division of Nephrology, University Hospital Carl Gustav Carus at the Technische Universität Dresden, 01307 Dresden, Germany; cDepartment of Pathology, Research Institute–Fundación Jiménez Díaz, School of Medicine, UAM, 28040 Madrid, Spain; dSchool of Medicine, UAM, 28029 Madrid, Spain; eInstituto Reina Sofía de Investigación Nefrológica, School of Medicine, UAM, 28040 Madrid, Spain; and fCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Research Institute-Fundación Jiménez Díaz, UAM, 28040 Madrid, Spain


Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES